2nd Quarter - Report

CROSSROADS STRATEGIES, LLC for ALTRIA CLIENT SERVICES LLC

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Natural Resources NAT

Implementation of Agriculture Improvement Act of 2018 (P.L.115-334).

LobbyistCovered position, as disclosed
SALIM ALAMEDDIN —
JASON GLEASON —
JOHN GREEN —
STEWART HALL —
SHAY MICHAEL HANCOCK —
MATHEW LAPINSKI —
HUNTER MOORHEAD —
TODD MATTHEW WEISS —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE; Office of Management & Budget (OMB); Executive Office of the President (EOP)

Budget/Appropriations BUD

Issues related to the regulation of tobacco products, crop research funding, and increasing the federal minimum age to purchase tobacco products to 21. H.R.3164, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2020 and H.R.3055, the FY2020 Consolidated measure. H.R.2740, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2020 and H.R.2740, the FY2020 Consolidated measure.

LobbyistCovered position, as disclosed
SALIM ALAMEDDIN —
JASON GLEASON —
JOHN GREEN —
STEWART HALL —
SHAY MICHAEL HANCOCK —
MATHEW LAPINSKI —
HUNTER MOORHEAD —
TODD MATTHEW WEISS —

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE; Office of Management & Budget (OMB); Executive Office of the President (EOP)

Bills named: H.R. 2740 (116th), H.R. 3164 (116th), H.R. 3055 (116th)

Tobacco TOB

Issues related to the regulation of tobacco products and increasing the federal minimum age to purchase tobacco products to 21. H.R.2411/S.1258, Tobacco to 21 Act. S.1541, Tobacco-Free Youth Act. H.R.2339, Reversing the Youth Tobacco Epidemic Act of 2019. S.9, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019.

LobbyistCovered position, as disclosed
SALIM ALAMEDDIN —
JASON GLEASON —
JOHN GREEN —
STEWART HALL —
SHAY MICHAEL HANCOCK —
MATHEW LAPINSKI —
HUNTER MOORHEAD —
TODD MATTHEW WEISS —

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Office of Management & Budget (OMB)

Bills named: S. 1541 (116th), H.R. 2411 (116th), S. 9 (116th), S. 1258 (116th), H.R. 2339 (116th)

Financial Institutions/Investments/Securities FIN

corporate governance issues

LobbyistCovered position, as disclosed
SALIM ALAMEDDIN —
JASON GLEASON —
JOHN GREEN —
STEWART HALL —
SHAY MICHAEL HANCOCK —
MATHEW LAPINSKI —
HUNTER MOORHEAD —
TODD MATTHEW WEISS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Office of Management & Budget (OMB); Executive Office of the President (EOP)

Taxation/Internal Revenue Code TAX

Monitoring tobacco excise tax issues.

LobbyistCovered position, as disclosed
SALIM ALAMEDDIN —
JASON GLEASON —
JOHN GREEN —
STEWART HALL —
SHAY MICHAEL HANCOCK —
MATHEW LAPINSKI —
HUNTER MOORHEAD —
TODD MATTHEW WEISS —

Contacted: SENATE; Executive Office of the President (EOP); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Health Issues HCR

CDC's implementation of health care funding provisions of the Patient Protection and Affordable Care Act (P.L.111-148).

LobbyistCovered position, as disclosed
SALIM ALAMEDDIN —
JASON GLEASON —
JOHN GREEN —
STEWART HALL —
SHAY MICHAEL HANCOCK —
MATHEW LAPINSKI —
HUNTER MOORHEAD —
TODD MATTHEW WEISS —

Contacted: Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Office of Management & Budget (OMB); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.